Heron Therapeutics share price today

(HRTX)

Heron Therapeutics share price is $1.53 & ₹130.12 as on 20 Dec 2024, 2.30 'hrs' IST

$1.53

▲

-0.04

(-2.55%)

Market is closed - opens 8 PM, 20 Dec 2024

View live Heron Therapeutics share price in Dollar and Rupees. Guide to invest in Heron Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Heron Therapeutics. Get details on the Indian mutual funds that are investing in Heron Therapeutics. Get Analyst recommendations and forecasts along with all the Heron Therapeutics's financials.

Heron Therapeutics share price movements

Today's Low: $1.50
Today's High: $1.60
$1.53
2.29%
Downside
Day's Volatility :6.56%
Upside
4.38%
52 Weeks Low: $1.04
52 Weeks High: $3.93
$1.53
32.03%
Downside
52 Weeks Volatility :73.54%
Upside
61.07%

Heron Therapeutics Returns

Period	Heron Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.73%	-12.2%	0.0%
6 Months	-52.63%	-6.9%	0.0%
1 Year	-12.07%	2.7%	0.0%
3 Years	-84.16%	-0.2%	-17.3%

Heron Therapeutics Key Statistics

in dollars & INR

Previous Close	$1.57
Open	$1.61
Today's High	$1.6
Today's Low	$1.495
Market Capitalization	$238.8M
Today's Volume	$2.0M
52 Week High	$3.93
52 Week Low	$1.04
Revenue TTM	$137.7M
EBITDA	$-5.7M
Earnings Per Share (EPS)	$-0.16
Profit Margin	-20.31%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-2408.88%

How to invest in Heron Therapeutics from India?

It is very easy for Indian residents to invest directly in Heron Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Heron Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Heron Therapeutics or HRTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Heron Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Heron Therapeutics shares which would translate to 0.556 fractional shares of Heron Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Heron Therapeutics, in just a few clicks!

Returns in Heron Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Heron Therapeutics investment value today

Current value as on today

₹1,14,247

Returns

₹14,247

(+14.25%)

Returns from Heron Therapeutics Stock

₹12,069 (false-12.07%)

Dollar Returns

₹2,178 (+2.18%)

Indian investors sentiment towards Heron Therapeutics

376.92%

Period: Sep 20, 2024 to Dec 19, 2024. Change in 30 Days versus previous period

Investment in Heron Therapeutics from India has grown in the last 30 days as on Dec 20, 2024. 376.92% more purchase transactions for Heron Therapeutics in the last 30 days versus the previous period.

295%

Period: Sep 20, 2024 to Dec 19, 2024. Change in 30 Days versus previous period

Search volume for Heron Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 20, 2024. 295% more investors are searching Heron Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Heron Therapeutics

Rubric Capital Management LP
17.56%
Adage Capital Partners Gp LLC
5.82%
Vanguard Group Inc
5.73%
BlackRock Inc
5.47%
Velan Capital Investment Management LP
4.59%
Tejara Capital Ltd
3.49%

Analyst Recommendation on Heron Therapeutics

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Heron Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Heron Therapeutics

What analysts predicted

Upside of 292.16%

Current:

$1.53

Target:

$6.00

Insights on Heron Therapeutics

Price Movement
In the last 1 month, HRTX stock has moved up by 36.6%
Increasing Revenue
Revenue is up for the last 5 quarters, 31.43M → 42.26M (in $), with an average increase of 7.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -9.23M → -4.84M (in $), with an average increase of 90.5% per quarter
HRTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 39.0%
HRTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 104.9%
Price to Sales
ForHRTX every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Heron Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$77.5M	↑ 151.81%
Net Income	$-178.8M	↓ 9.44%
Net Profit Margin	-230.84%	↑ 411.03%

	FY19	Y/Y Change
Revenue	$146.0M	↑ 88.41%
Net Income	$-204.7M	↑ 14.49%
Net Profit Margin	-140.27%	↑ 90.57%

	FY20	Y/Y Change
Revenue	$88.6M	↓ 39.28%
Net Income	$-224.4M	↑ 9.61%
Net Profit Margin	-253.2%	↓ 112.93%

	FY21	Y/Y Change
Revenue	$86.3M	↓ 2.59%
Net Income	$-217.7M	↓ 3.02%
Net Profit Margin	-252.08%	↑ 1.12%

	FY22	Y/Y Change
Revenue	$107.7M	↑ 24.7%
Net Income	$-134.5M	↓ 38.2%
Net Profit Margin	-124.93%	↑ 127.15%

	FY23	Y/Y Change
Revenue	$127.0M	↑ 17.99%
Net Income	$-110.6M	↓ 17.81%
Net Profit Margin	-87.02%	↑ 37.91%

	Q2 FY23	Q/Q Change
Revenue	$31.8M	↑ 7.25%
Net Income	$-42.1M	↑ 29.52%
Net Profit Margin	-132.42%	↓ 22.77%

	Q3 FY23	Q/Q Change
Revenue	$31.4M	↓ 1.03%
Net Income	$-25.0M	↓ 40.54%
Net Profit Margin	-79.56%	↑ 52.86%

	Q4 FY23	Q/Q Change
Revenue	$34.2M	↑ 8.9%
Net Income	$-10.7M	↓ 57.12%
Net Profit Margin	-31.33%	↑ 48.23%

	Q1 FY24	Q/Q Change
Revenue	$34.7M	↑ 1.28%
Net Income	$-3.2M	↓ 70.53%
Net Profit Margin	-9.11%	↑ 22.22%

	Q2 FY24	Q/Q Change
Revenue	$36.0M	↑ 3.91%
Net Income	$-9.2M	↑ 192.25%
Net Profit Margin	-25.64%	↓ 16.53%

	Q3 FY24	Q/Q Change
Revenue	$42.3M	↑ 17.33%
Net Income	$-4.8M	↓ 47.5%
Net Profit Margin	-11.47%	↑ 14.17%

	FY18	Y/Y Change
Profit	$50.0M	↑ 90.85%

	FY19	Y/Y Change
Profit	$84.3M	↑ 68.83%

	FY20	Y/Y Change
Profit	$52.4M	↓ 37.82%

	FY21	Y/Y Change
Profit	$40.3M	↓ 23.12%

	FY22	Y/Y Change
Profit	$52.8M	↑ 30.93%

	FY23	Y/Y Change
Profit	$61.9M	↑ 17.31%

	Q2 FY23	Q/Q Change
Profit	$11.6M	↓ 9.07%

	Q3 FY23	Q/Q Change
Profit	$13.2M	↑ 13.98%

	Q4 FY23	Q/Q Change
Profit	$24.3M	↑ 84.09%

	Q1 FY24	Q/Q Change
Profit	$26.2M	↑ 7.71%

	Q2 FY24	Q/Q Change
Profit	$25.5M	↓ 2.75%

	Q3 FY24	Q/Q Change
Profit	$23.4M	↓ 8.45%

	FY18	Y/Y Change
Operating Cash Flow	$-191.8M	↑ 12.63%
Investing Cash Flow	$-278.6M	↓ 3699.77%
Financing Cash Flow	$357.6M	↑ 21.75%

	FY19	Y/Y Change
Operating Cash Flow	$-124.6M	↓ 35.05%
Investing Cash Flow	$-21.8M	↓ 92.18%
Financing Cash Flow	$186.4M	↓ 47.87%

	FY20	Y/Y Change
Operating Cash Flow	$-184.8M	↑ 48.35%
Investing Cash Flow	$209.0M	↓ 1059.26%
Financing Cash Flow	$9.1M	↓ 95.12%

	FY21	Y/Y Change
Operating Cash Flow	$-203.4M	↑ 10.03%
Investing Cash Flow	$32.7M	↓ 84.34%
Financing Cash Flow	$156.0M	↑ 1613.65%

	FY22	Y/Y Change
Operating Cash Flow	$-146.9M	↓ 27.76%
Investing Cash Flow	$-3.3M	↓ 110.16%
Financing Cash Flow	$75.1M	↓ 51.89%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-27.2M	↑ 9.1%
Investing Cash Flow	$13.2M	↓ 64.11%
Financing Cash Flow	$319.0K	↓ 253.37%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-9.2M	↓ 66.21%
Investing Cash Flow	$-23.2M	↓ 275.68%
Financing Cash Flow	$53.8M	↑ 16764.26%

Heron Therapeutics Technicals Summary

Sell

Neutral

Buy

Heron Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Heron Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Heron Therapeutics, Inc.	36.61%	-52.63%	-12.07%	-84.16%	-93.93%
Regeneron Pharmaceuticals, Inc.	-4.72%	-32.75%	-15.87%	16.72%	89.27%
Biontech Se	9.01%	31.55%	7.5%	-58.98%	220.59%
Alnylam Pharmaceuticals, Inc.	-3.99%	44.16%	31.87%	19.68%	103.59%
Vertex Pharmaceuticals Incorporated	-12.1%	-15.38%	-1.0%	81.45%	80.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Heron Therapeutics, Inc.	NA	NA	-0.18	-0.12	-24.09	-0.02	NA	-0.26
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.05	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Heron Therapeutics, Inc.	Buy	$238.8M	-93.93%	NA	-20.31%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	89.27%	17.67	33.61%
Biontech Se	Buy	$26.8B	220.59%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.7B	103.59%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$115.2B	80.31%	32.84	-4.51%

About Heron Therapeutics

heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

Organization	Heron Therapeutics
Employees	126
CEO	Mr. Craig Alexander Collard
Industry	Health Technology

Management People of Heron Therapeutics

Name	Title
Mr. Craig Alexander Collard	CEO & Director
Ms. Ira Duarte	Executive VP & CFO
Dr. William P. Forbes Pharm. D., Pharm.D.	Executive VP & Chief Development Officer
Mr. Ryan Craig	Vice President of Marketing
Mr. Sean T. Ristine	Senior Vice President of Human Resources
Mr. Robert Sullivan	Senior Vice President of Oncology Care Franchise & Commercial Operations
Mr. Brett Fleshman	Chief Business Officer
Jeff Cohn	Executive Director, Assistant General Counsel & Assistant Secretary

Important FAQs about investing in Heron Therapeutics from India :

What is Heron Therapeutics share price today?

Heron Therapeutics share price today stands at $1.53, Open: $1.61 ; Previous Close: $1.57 ; High: $1.60 ; Low: $1.50 ; 52 Week High: $3.93 ; 52 Week Low: $1.04. The stock opens at $1.61, after a previous close of $1.57. The stock reached a daily high of $1.60 and a low of $1.50, with a 52-week high of $3.93 and a 52-week low of $1.04.

Can Indians buy Heron Therapeutics shares?

Yes, Indians can invest in the Heron Therapeutics (HRTX) from India.

With INDmoney, you can buy Heron Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Heron Therapeutics at zero transaction cost.

How can I buy Heron Therapeutics shares from India?

It is very easy to buy Heron Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Heron Therapeutics be purchased?

Yes, you can buy fractional shares of Heron Therapeutics with INDmoney app.

What are the documents required to start investing in Heron Therapeutics stocks?

To start investing in Heron Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.